Literature DB >> 28134927

Opioids: keeping the good, eliminating the bad.

Stephanie Puig1, Howard B Gutstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28134927      PMCID： PMC6602584          DOI： 10.1038/nm.4277

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Opioid-induced long-term potentiation in the spinal cord is a presynaptic event.

Authors:  Hong-Yi Zhou; Shao-Rui Chen; Hong Chen; Hui-Lin Pan
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

Review 2.  The development and maintenance of drug addiction.

Authors:  Roy A Wise; George F Koob
Journal:  Neuropsychopharmacology       Date:  2013-10-11       Impact factor: 7.853

Review 3.  Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies.

Authors:  Nora D Volkow; A Thomas McLellan
Journal:  N Engl J Med       Date:  2016-03-31       Impact factor: 91.245

Review 4.  A comprehensive review of opioid-induced hyperalgesia.

Authors:  Marion Lee; Sanford M Silverman; Hans Hansen; Vikram B Patel; Laxmaiah Manchikanti
Journal:  Pain Physician       Date:  2011 Mar-Apr       Impact factor: 4.965

5.  Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes.

Authors:  D H Kim; H L Fields; N M Barbaro
Journal:  Brain Res       Date:  1990-05-14       Impact factor: 3.252

6.  Induction of synaptic long-term potentiation after opioid withdrawal.

Authors:  Ruth Drdla; Matthias Gassner; Ewald Gingl; Jürgen Sandkühler
Journal:  Science       Date:  2009-07-10       Impact factor: 47.728

Review 7.  Opioid-induced hyperalgesia: Cellular and molecular mechanisms.

Authors:  Laurie-Anne Roeckel; Glenn-Marie Le Coz; Claire Gavériaux-Ruff; Frédéric Simonin
Journal:  Neuroscience       Date:  2016-06-23       Impact factor: 3.590

Review 8.  Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation.

Authors:  Catherine M Cahill; Wendy Walwyn; Anna M W Taylor; Amynah A A Pradhan; Christopher J Evans
Journal:  Trends Pharmacol Sci       Date:  2016-09-23       Impact factor: 14.819

9.  Blockade of PDGFR-β activation eliminates morphine analgesic tolerance.

Authors:  Yan Wang; Katherine Barker; Shanping Shi; Miguel Diaz; Bing Mo; Howard B Gutstein
Journal:  Nat Med       Date:  2012-02-19       Impact factor: 53.440

10.  Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.

Authors:  Gregory Corder; Vivianne L Tawfik; Dong Wang; Elizabeth I Sypek; Sarah A Low; Jasmine R Dickinson; Chaudy Sotoudeh; J David Clark; Ben A Barres; Christopher J Bohlen; Grégory Scherrer
Journal:  Nat Med       Date:  2017-01-16       Impact factor: 53.440
View more
  4 in total

1.  Ethanol Reversal of Oxycodone Tolerance in Dorsal Root Ganglia Neurons.

Authors:  Joanna C Jacob; Kensuke Sakakibara; Ryan A Mischel; Graeme Henderson; William L Dewey; Hamid I Akbarali
Journal:  Mol Pharmacol       Date:  2018-02-21       Impact factor: 4.436

2.  Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.

Authors:  Launette Marie Rieb; Kora DeBeck; Kanna Hayashi; Evan Wood; Ekaterina Nosova; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2020-08-18       Impact factor: 4.492

3.  Morphine enhances LPS-induced macrophage apoptosis through a PPARγ-dependent mechanism.

Authors:  Mingying Lin; Keqiong Deng; Ya Li; Jing Wan
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

4.  Inhibiting Hv1 channel in peripheral sensory neurons attenuates chronic inflammatory pain and opioid side effects.

Authors:  Qiansen Zhang; Yimin Ren; Yiqing Mo; Peipei Guo; Ping Liao; Yuncheng Luo; Jie Mu; Zhuo Chen; Yang Zhang; Ya Li; Linghui Yang; Daqing Liao; Jie Fu; Juwen Shen; Wei Huang; Xuewen Xu; Yanyan Guo; Lianghe Mei; Yunxia Zuo; Jin Liu; Huaiyu Yang; Ruotian Jiang
Journal:  Cell Res       Date:  2022-02-03       Impact factor: 46.297
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.